Pdt Partners, LLC Bridge Bio Pharma, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $60,666 - $103,691	-9,001 Reduced 7.13%	117,292 $893,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $1 Million - $1.56 Million	126,293 New	126,293 $1.26 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $288,805 - $672,956	-55,433 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $406,878 - $951,230	55,433 New	55,433 $563,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.